Is AI Drug Discovery Finally Here? - with Daphne Koller

The podcast episode centers on Israeli tech, economic trends, and the intersection of AI and biotech. It highlights the $1 billion raised by Israeli startups in January, marking the strongest start since 2022, while also noting the underperformance of the Windex, particularly with SaaS companies like Monday.com facing AI headwinds. The acquisition of QAI by Apple for nearly $2 billion is discussed as a testament to Israel's robust tech ecosystem. The episode features Daphne Koller, CEO of Insitro, who shares insights on AI-driven drug discovery and the company's acquisition of Combinable.ai in Israel, emphasizing the need for interdisciplinary talent in bioinformatics and digital health. The discussion also touches on the UN's financial instability and its potential implications for international law and Israel.